Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2.

MLA

Valk, P., et al. “Enhancement of Erythropoietin-Stimulated Cell Proliferation by Anandamide Correlates with Increased Activation of the Mitogen-Activated Protein Kinases ERK1 and ERK2.” The Hematology Journal : The Official Journal of the European Haematology Association, vol. 1, no. 4, 2000, pp. 254–63. EBSCOhost, https://doi.org/10.1038/sj.thj.6200036.

APA

Valk, P., Verbakel, S., von Lindern, M., Löwenberg, B., & Delwel, R. (2000). Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2. The Hematology Journal : The Official Journal of the European Haematology Association, 1(4), 254–263. https://doi.org/10.1038/sj.thj.6200036

Chicago

Valk, P, S Verbakel, M von Lindern, B Löwenberg, and R Delwel. 2000. “Enhancement of Erythropoietin-Stimulated Cell Proliferation by Anandamide Correlates with Increased Activation of the Mitogen-Activated Protein Kinases ERK1 and ERK2.” The Hematology Journal : The Official Journal of the European Haematology Association 1 (4): 254–63. doi:10.1038/sj.thj.6200036.